Complex Metabolic Diseases and Mitochondria news

<p>Image: University of Barcelona</p>
13 Apr 2018

The new study analyses the dysfunction of basolateral transporters through a transgenic animal model.

This study is led by Manuel Palacín from IRB Barcelona and Virgínia Nunes from IDIBELL.

<p>Image: La Vanguardia</p>
11 Apr 2018

La Vanguardia has published an article about the "Vanguardia de la Ciencia" award ceremony. The winners of these awards were selected by readers, who vote among eight Spanish researchers in the field of physics, chemistry, biology and social sciences. Marc Claret, at IDIBAPS, and Antonio Zorzano, at IRB Barcelona, came third for their research on the connection between the hypothalamus and the pancreas.

Link to La Vanguardia

<p>Mitochondrial DNA stress (in red) triggers the inflammatory response in mouse muscle cells devoid of Opa1 (nuclei in green). Aida Rodríguez, IRB Barcelona</p>
9 Apr 2018

A study performed at IRB Barcelona supports the notion that mitochondrial defects underlie a set of diseases of unknown origin that involve chronic muscle inflammation.

<p>Image: La Vanguardia</p>
6 Mar 2018

La Vanguardia newspaper has published an article congratulating the winners of the "Vanguardia de la Ciencia" Award. The third place went to the research done by Marc Claret, at IDIBAPS, and Antonio Zorzano, head of the Complex Metabolic Diseases and Mitochondria Laboratory at IRB Barcelona. This study, discovered that a small group of neurons communicates with the pancreas to regulate the release of insulin. This finding thus, represents an advance in the understanding of type 2 diabetes.

Link to La Vanguardia

<p>Image: La Vanguardia</p>
5 Mar 2018

La Vanguardia newspaper published an article about the winners of the "Vanguardia de la Ciencia" Award, organised by the same newspaper and the Catalunya-La Pedrera Foundation. A study by Marc Claret from IDIBAPS and Antonio Zorzano from IRB Barcelona revealing that a small group of neurons communicates with the pancreas to regulate the release of insulin got third place. This finding is an advance in the understanding of type 2 diabetes.

Link to La Vanguardia

<p>Image: La Vanguardia</p>
30 Jan 2018

Antonio Zorzano from IRB Barcelona and Marc Claret from IDIBAPS have been nominated for the “Vanguardia de la Ciencia” award. Their research reveals the connection between the hypothalamus and pancreas.

Link to La Vanguardia

<p>Cells with elongated mitochondrial network in red. Image: David Sebastián, IRB Barcelona</p>
23 Jan 2018

La Vanguardia, La Razón, Correo Farmacéutico, Health Canal, among other national and international media, have published an article about the research led by Antonio Zorzano, from IRB Barcelona, and Fernando Albericio, from the University of Barcelona. This study reveals activators of mitochondrial protein Mitofusin 2 that may be valuable in the treatment of type 2 diabetes.

Link to La Vanguardia

Link to...

<p>Cells with elongated mitochondrial network in red. Image: David Sebastián, IRB Barcelona</p>
18 Jan 2018

A team headed by Antonio Zorzano at IRB Barcelona has identified activators of the mitochondrial protein Mitofusin 2 for the treatment of type 2 diabetes.

The protein is a key regulator of many mitochondrial functions, as well as of the cell as a whole.

<p>Jordi Coste (on the right of the image), accompanied by the "A future in biomedicine" 2015 students: Pau de Jorge, Anna Ferrer, Eduard Puig and Enric Ros (from left to right).</p>
31 Oct 2017

After spending three years as a Visiting Student in the Complex Metabolic Diseases and Mitochondria Lab led by Antonio Zorzano, Jordi Coste (b. Barcelona, 1993) is about to embark on new projects in the United States. This young scientist is leaving behind what he considers “a big family” at IRB Barcelona to pursue a career more focused on clinical counselling. But before crossing the pond, he has found time to look back on his years with us: “The Institute has helped me to improve my critical and logical thinking skills, and this will definitely help me in the future.”

17 Oct 2017

Professor Antonio Zorzano is the president of the FEBS3+ Congress as well as programme head at IRB Barcelona and the Diabetes and Associated Metabolic Diseases Networking Biomedical Research Centre (CIBERDEM).